Details for 2016702654

Up to date per 02.04.2026

Actions

Title / Product Name

TOSYLATSALZ VON N-[3-[(4AR,7AS)-2-AMINO-6-(5-FLUORPYRIMIDIN-2-YL)-4,4A,5,7-TETRAHYDROPYRROLO[3,4-D][1,3]THIAZIN-7A-YL]-4-FLUOR-PHENYL]-5-METHOXY-PYRAZIN-2-CARBOXAMID

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2016702654

EP Publication Number

3250575

E-Number

1204100

Language

PCT Number

US16014423

Publication Date

06.12.2017 A

20.11.2019 B1

Registration Date

20.11.2019

AT Publication Date

15.12.2019

Application Date

22.01.2016

Registration Number

Priorities

30.01.2015

201562109733 P

IPC

C07D 513/04 20060101AFI20160812BHEP

Maximum Duration of Protection

22.01.2036

Owner

Eli Lilly and CompanyLilly Corporate Center Indianapolis, IN 46285US

Representative

Schwarz & Partner Patentanwälte OGWipplingerstraße 301010 WienAT

Inventor

COATES, David Andrewc/o Eli Lilly and Company P.O. Box 6288 Indianapolis, Indiana 46206-6288US

WOLFANGEL, Craig Danielc/o Eli Lilly and Company P.O. Box 6288 Indianapolis, Indiana 46206-6288US

Information about Fees